Clearstead Advisors’s Aspira Women's Health Inc. Common Stock AWH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-495
Closed -$3K 1396
2022
Q3
$3K Hold
495
﹤0.01% 1058
2022
Q2
$4K Hold
495
﹤0.01% 1044
2022
Q1
$8K Hold
495
﹤0.01% 1025
2021
Q4
$13K Hold
495
﹤0.01% 904
2021
Q3
$24K Hold
495
﹤0.01% 759
2021
Q2
$42K Hold
495
﹤0.01% 590
2021
Q1
$50K Buy
+495
New +$54.4K ﹤0.01% 546

Other funds holding AWH

Clearstead Advisors's AWH Position: Q4 2022 in Review

Clearstead Advisors sold out of Aspira Women's Health Inc. Common Stock (AWH) in Q4 2022, closing a stake of 495 shares — an estimated $3K sold.

Clearstead Advisors first reported a position in AWH in Q1 2021 and held it in 7 quarters. The position peaked at $50K in Q1 2021. 47 funds tracked by Wall St. Rank hold AWH as of Q4 2022.

  • Clearstead Advisors reported no remaining Aspira Women's Health Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Clearstead Advisors sold 495 Aspira Women's Health Inc. Common Stock shares in Q4 2022, an estimated $3K.
  • Clearstead Advisors first reported a position in Aspira Women's Health Inc. Common Stock in Q1 2021 and held it in 7 quarters.
  • Clearstead Advisors's Aspira Women's Health Inc. Common Stock position peaked at $50K in Q1 2021.
  • 47 funds tracked by Wall St. Rank held Aspira Women's Health Inc. Common Stock as of Q4 2022.

Based on Clearstead Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.